Mindverse Computing · Investment Opportunity

The Agentic Quantum Digital Twin Platform

Building the state-to-recommendation platform for real-world complex systems. From biology and finance to materials and neuroscience, one framework connects quantum-classical simulation with agentic workflows across four markets.

Schedule a Meeting Explore Market Data

Investment at a Glance

The first mover in multi-domain agentic quantum digital twins, a platform where every new domain strengthens every other.

$250B+

Market Opportunity

Finance, Materials, Genomics & Neuroscience, all addressable through one unified agentic quantum digital twin platform

4

Agentic Quantum Digital Twins

QVF, QVMa, QVO, and QVM, four dedicated engines built on a single proprietary simulation and recommendation framework

1st

First-Mover Advantage

A platform delivering agentic quantum digital twins across four domains simultaneously

12+

Revenue Streams

Cloud APIs, SaaS subscriptions, drug discovery milestones, portfolio analytics, pharma partnerships, and enterprise simulation contracts

4

Growing Domain Portfolio

Active development across Finance, Matter, Genomics, and Neuroscience — with an extensible platform for new domains

Global

Scalable Platform

Cloud-native quantum-classical engine with agentic workflows deployable on IBM Quantum, NVIDIA CUDA-Q, and classical clusters worldwide

Domain Investment Opportunities

Each domain represents an independent revenue engine and market beachhead. Together, they form a compounding agentic quantum platform with structural defensibility across all four markets.

Quantitative Finance

Quantum Virtual Finance  QVF

The $140B+ quantitative finance market has limited quantum-native analytics coverage. QVF delivers market-state Hamiltonian modeling, quantum regime detection, and agentic risk triage to institutional investors.

Investment Thesis: Quantum finance is at the same inflection point as quantitative computing was in 1990. QVF has an 18–24 month window of first-mover advantage before larger players enter.

$140B+
Quant Finance TAM
$10K–$500K
Annual SaaS per Client
Revenue Streams
  • B2B SaaS subscriptions for hedge funds and asset managers
  • Risk API licensing for fintech and analytics platforms
  • White-label portfolio analytics for institutional brokers
  • Enterprise on-premise deployment for tier-1 banks
Quantum Chemistry & Materials

Quantum Virtual Matter  QVMa

A $250B+ combined opportunity across battery materials, semiconductor design, green chemistry, and pharmaceutical molecular simulation. QVMa supports faster R&D cycles through quantum-accurate molecular dynamics and agentic candidate prioritization.

Investment Thesis: The clean energy transition and semiconductor race create massive demand for quantum materials simulation. QVMa sits at the intersection of the $400B pharma R&D and $30B computational chemistry markets.

$250B+
Addressable Market
$50K–$500K
Enterprise License/yr
Revenue Streams
  • Enterprise simulation SaaS for pharma and materials companies
  • Pharma milestone payments ($1M–$50M per compound validated)
  • Battery and semiconductor materials R&D API access
  • Co-development agreements with energy and chemical companies
Genomics & Drug Discovery

Quantum Virtual Omics  QVO

Drug discovery costs $2.6B per approved compound. QVO's quantum virtual cell models reason about efficacy, toxicity, and interactions through pathway-coupled simulation, helping research teams prioritize compounds and de-risk discovery programs.

Investment Thesis: AI drug discovery is already $50B+ by 2030. QVO brings a quantum physics advantage that pure ML cannot replicate — modeling actual cellular biophysics, not pattern matching.

$50B+
AI Drug Discovery TAM
$1M–$50M
Per Compound Milestone
Revenue Streams
  • Drug discovery milestone payments from pharma partnerships
  • Genomics analytics API subscription for research labs
  • Precision medicine platform licensing for health systems
  • CRO partnerships for ADMET profiling services
Neuroscience & BCI

Quantum Virtual Mind  QVM

BCI devices are entering consumer and clinical markets. QVM provides an agentic brain-state decoding layer for BCI platforms, supporting precision neuroscience research and cognitive-state workflows at scale.

Investment Thesis: The $8B+ BCI market has no quantum-native signal processing layer. QVM enters as an enabling SDK and analytical platform, capturing value across every BCI hardware deployment without competing with device makers.

$8B+
BCI Market by 2027
$500B
Mental Health Market
Revenue Streams
  • BCI OEM embedded SDK licensing (per-device royalty model)
  • Mental health platform data analytics subscription
  • Clinical neurology diagnostic software licensing
  • Digital therapeutics integration fees and telehealth partnerships

Why Invest Now?

Multiple converging markets are simultaneously reaching inflection. The first-mover window is open today — and closing fast.

🎯 Market Timing

  • ✓ Quantum computers reaching commercial utility (IBM 1000+ qubit, Google Willow)
  • ✓ BCI devices entering consumer market (Neuralink, OpenBCI, Emotiv scaling)
  • ✓ AI-driven drug discovery market exceeding $50B by 2030
  • ✓ Clean energy transition driving $250B+ battery and materials R&D
  • ✓ Quantitative finance demanding quantum-native risk models post-2020 volatility
  • ✓ First-mover window open across four converging markets simultaneously

💰 Use of Funds

R&D & Engineering 40%
Sales & Marketing 30%
Infrastructure & Cloud 20%
Operations & Legal 10%

Ready to Back the Platform?

Join us at the convergence of quantum computing, AI, and real-world domain intelligence as agentic quantum digital twins move from state reconstruction to recommendations.

Schedule a Meeting Explore Market Data